Conservative Treatment for Atypical Endometrial Hyperplasia and Early Endometrial Cancer
Not yet recruiting
- Conditions
- Atypical Endometrial Hyperplasia and Endometrial Cancer
- Registration Number
- NCT06170684
- Lead Sponsor
- Beijing Obstetrics and Gynecology Hospital
- Brief Summary
Exploring the efficacy and pregnancy outcomes of conservative treatment for atypical endometrial hyperplasia and endometrial cancer. Study the factors related to predicting treatment efficacy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
- (1) age ≤ 45 years old, strong desire to preserve reproductive function, and no factors of reproductive dysfunction evaluated before treatment; (2) The pathological type is atypical endometrial hyperplasia or endometrial cancer; (3) Imaging examination confirmed that the tumor was localized to the endometrium; (4) There are follow-up conditions available.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete remission rate 6months
- Secondary Outcome Measures
Name Time Method